Posaconazole

泊沙康唑

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NamePosaconazole
Drug Alias NamePosaconazol泼康唑泊沙抗唑Posaconazolum诺科飞 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsNail InfectionsJob SyndromeGranulomatous Disease, Chronic +[21] 
Global Approved IndicationsCoccidioidomycosisCandidiasisAspergillosis +[4] 
Approved Indications in ChinaCandidiasisAspergillosisMycoses
Original Approved Country/TerritoryEU
Original Approved Date2005/10/25
Country/TerritoryCzechiaBelgiumCanada +[44] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaMerck Sharp & Dohme BvSchering Corp +[7] 
Inactive CompaniesRadboud University Medical CenterSchering-PloughMerck Sharp & Dohme Corp +[14] 
Active IndicationsNail InfectionsMyelodysplastic SyndromesAnemia, Aplastic +[10] 
Inactive IndicationsJob SyndromeGranulomatous Disease, ChronicNeutropenia +[11] 

Other Information

ATC CodeJ02AC04
Related LinksWikipediaDrugBankKEGG